Self-monitoring of blood glucose as an essential component of exerting total control over diabetes

Cover Page

Cite item

Full Text

Abstract

Diabetes mellitus (DM) is a chronic disease associated with the development of micro-and macrovascular complications, prevention of which is an important task of modern medicine. Achieving and maintaining blood glucose levels close to normal, however, is almost impossible without the full participation of the patient in the treatment of diabetes. Self-monitoring of blood glucose (SAG) is the basis of the effectiveness of glucose-lowering therapy and prevention of hypoglycemia. This article discusses the recommended frequency of SCG depending on the type of diabetes. For measuring blood sugar at home now a variety of devices is available. Selection of quality meter is determined by ease of use, ease of operation of the device, ease of preparation and fair presentation of results of the results of measurement.

About the authors

E. V Biryukova

Evdokimov Moscow State University of Medicine and Dentistry

д-р мед. наук, проф. каф. эндокринологии и диабетологии

References

  1. Gerstein H.C, Miller M.E, Byington R.P et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-59.
  2. Khaled A.A, Sekaran M, Ikram S.I. Type 2 diabetes and vascular complications: A pathophysiologic view. Biomedical Research 2010; 21 (2): 147-50.
  3. Ruigomez A, Rodrigues L.A. Presence of diabetes related complication at the time of NIDDM diagnosis: an important prognostic factor. Eur J Epidemiol 1998; 14 (15): 439-45.
  4. Chen L, Magliano D.J, Zimmet P.Z. The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives. Nat Rev Endocrinol 2012; 8: 228-36.
  5. Koro C.E, Bowlin S.J, Bourgeois N et al. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004; 27: 17-20.
  6. Zoungas S, Patel A. Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapies. Ann N Y Acad Sci 2010; 1212 (1): 29-40.
  7. Holman R.R, Paul S.K, Bethel M.A et al. 10-year follow - up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-89.
  8. Patel A, Mac Mahon S, Chalmers J et al. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-72.
  9. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood - glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes. (UKPDS 34). Lancet 1998; 352: 837-53.
  10. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. Изд. 6-е. М., 2013.
  11. Бергер М., Старостина Е.Г., Йоргенс В. и др. Практика инсулинотерапии. Берлин: Springer, 1995.
  12. Freckmann G, Schmid C, Baumstark A et al. Diabetes Science and Technology 2012; 6 (5): 1060-74.
  13. Mc Geoch G, Derry S, Moore R.A. Self - monitoringof blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev 2007; 23: 423-40.
  14. Davidson M.B, Castellanos M, Kain D et al. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005; 118: 422-5.
  15. Farmer A, Wade A, Goyder E et al. Impact of self monitoring of blood glucose in the management of patients with non - insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 13.
  16. O’Kane M J, Bunting B, Copeland M et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008; 336: 1174-7.
  17. Майоров А.Ю. Самоконтроль метаболических параметров у больных сахарным диабетом на современном этапе. Фарматека, 2006; 17: 69-84.
  18. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Вопросы самоконтроля гликемии в практике лечения сахарного диабета. Справ. поликлин. врача. 2012; 12: 32-6.
  19. Blonde L, Karter A.J. Current evidence regarding the value of self monitored blood glucose testing. Am J Med 2005; 118 (Suppl. 9A): 20S-6S.
  20. International Organization for Standardization. In vitro diagnostic test systems. Requirements for blood - glucose monitoring system for self - testing in managing diabetes mellitus. Reference number ISO 15197: 2003 (E). Geneva: International Organization for Standardization 2003.
  21. Kuo C.Y, Hsu C.T, Ho C.S et al. Accuracy and precision evaluation of seven self - monitoring blood glucose systems. Diabetes Technol Ther 2011; 13: 596-600.

Copyright (c) 2014 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies